The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure
Open accessAbstract
Background: Combination diuretic regimens to overcome loop diuretic resistance (DR) are commonly utilized with limited evidence. Objective: Compare combination diuretic strategies in acute heart failure (AHF) complicated by DR Methods: We conducted a randomized, double-blinded trial in 60 patients hospitalized with AHF and intravenous (IV) loop DR. Patients were randomized to oral metolazone, IV chlorothiazide, or tolvaptan. All patients received concomitant high-dose IV furosemide infusions. The primary outcome was 48-hour weight loss. Results: The cohort exhibited DR prior to enrollment, producing 1188 ± 476 ml of urine in 12 hours during high-dose loop diuretics (IV furosemide 612 ± 439 mg/day). All 3 interventions significantly improved diuretic efficacy (p<0.001). Compared to metolazone (4.6 ± 2.7 kg), neither IV chlorothiazide (5.8 ± 2.7 kg), (1.2kg [95% CI −2.9 to 0.6]; p=0.292) or tolvaptan (4.1 ± 3.3 kg), (0.5kg [95% CI −1.5 to 2.4]; p=0.456) resulted in more weight loss at 48-hours. Cumulative urine output increased significantly and did not differ between metolazone (7.78 [6.59, 10.10] L) and chlorothiazide (8.77 [7.37, 10.86] L, p=0.245) or tolvaptan (9.70 [6.36, 13.81] L, p=0.160). Serum sodium decreased less with tolvaptan than metolazone (+4 ± 5 vs −1 ± 3 mEq/L, p =0.001), but 48-hour spot urine sodium was lower with tolvaptan (58 ± 25 mmol/L) than metolazone (104 ± 16 mmol/L, p=0.002) and chlorothiazide (117 ± 14 mmol/L, p<0.001) Conclusions: In this moderate-sized diuretic resistance trial, weight loss was excellent with addition of metolazone, IV chlorothiazide or tolvaptan to loop diuretics without a detectable between-group difference.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Mullens, W., Damman, K., Harjola, V.-P., Mebazaa, A., Brunner-La Rocca, H.-P., Martens, P., Testani, J. M., Tang, W. H. W., Orso, F., Rossignol, P., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1369 · Cited by 1,119
Self-citation
Cited by
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Authors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,171
Diuretic Therapy for Patients With Heart Failure
Felker, G. M., Ellison, D. H., Mullens, W., Cox, Z. L., & Testani, J. M. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.059 · Cited by 438
Self-citation
Metadata
- Authors
- Cox, Z. L., Hung, R., Lenihan, D. J., & Testani, J. M.
- Venue
- JACC: Heart Failure
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 8
- Issue
- 3
- Pages
- 157-168
- ISSN
- 2213-1779 (ISSN-L)
- OpenAlex
- W2995550955
- Cited by
- 189
- References
- 2
- FWCI
- 11.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure. https://app.cochat.ai/papers/10.1016/j.jchf.2019.09.012
- The paper
- Cox, Z. L., Hung, R., Lenihan, D. J., & Testani, J. M. (2020). Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2019.09.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.